|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 919 DKK | -5.26% |
|
-5.86% | +31.64% |
| 05:11pm | European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading | MT |
| 01:48pm | Novo Nordisk to Update Weight Loss Drugs Labels Over EMA's Safety Recommendation | MT |
Novo Nordisk A/S reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was DKK 65,863 million compared to DKK 48,092 million a year ago. Net income was DKK 21,963 million compared to DKK 13,592 million a year ago.
Basic earnings per share from continuing operations was DKK 4.92 compared to DKK 3.02 a year ago. Diluted earnings per share from continuing operations was DKK 4.91 compared to DKK 3.01 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +31.64% | 627B | |
| +55.35% | 848B | |
| -0.10% | 363B | |
| +15.47% | 318B | |
| +13.10% | 299B | |
| +15.51% | 243B | |
| +16.72% | 225B | |
| +16.54% | 179B | |
| +4.31% | 167B | |
| +2.52% | 125B |
NOVO NORDISK A/S 
